Episode 3: How Biomarkers Are Catalyzing Hope

For too long, misdiagnosis has been the frustrating reality of living with PSP. But a biomarker could finally change that, and revolutionize how new drugs are developed and tested.

We break down what biomarkers are and why they matter, then turn to the campaign the CurePSP community built to fund the search for one: the Biomarker Accelerator Program. Learn about the donors who got it off the ground and why combining multiple approaches is the most promising path forward.

Explore the Biomarker Accelerator Program.